Search Results - "Campbell, Toby C."

Management of Dyspnea in Advanced Cancer: ASCO Guideline by Hui, David, Bohlke, Kari, Bao, Ting, Campbell, Toby C, Coyne, Patrick J, Currow, David C, Gupta, Arjun, Leiser, Aliza L, Mori, Masanori, Nava, Stefano, Reinke, Lynn F, Roeland, Eric J, Seigel, Carole, Walsh, Declan, Campbell, Margaret L

“…To provide guidance on the clinical management of dyspnea in adult patients with advanced cancer. ASCO convened an Expert Panel to review the evidence and…”
Get full text

"Best Case/Worst Case": Qualitative Evaluation of a Novel Communication Tool for Difficult in-the-Moment Surgical Decisions by Kruser, Jacqueline M., Nabozny, Michael J., Steffens, Nicole M., Brasel, Karen J., Campbell, Toby C., Gaines, Martha E., Schwarze, Margaret L.

“…Objectives To evaluate a communication tool called “Best Case/Worst Case” (BC/WC) based on an established conceptual model of shared decision‐making. Design…”
Get full text

“Best Case/Worst Case”: Training surgeons to use a novel communication tool for high-risk acute surgical problems by Kruser, Jacqueline M., MD, Taylor, Lauren J., MD, Campbell, Toby C., MD, MSCI, Zelenski, Amy, PhD, Johnson, Sara K., MD, Nabozny, Michael J., MD, Steffens, Nicole M., MPH, Tucholka, Jennifer L., BS, Kwekkeboom, Kris L., PhD, RN, Schwarze, Margaret L., MD, MPP

“…Abstract Context Older adults often have surgery in the months preceding death, which can initiate post-operative treatments inconsistent with end-of-life…”
Get full text

Comparison of weekly versus every 3 weeks paclitaxel in the treatment of advanced solid tumors: A meta-analysis by Huang, Ta-Chen, Campbell, Toby C

“…Abstract Background Paclitaxel is commonly given as a 3-h infusion every 3 weeks for a variety of malignancies. Several randomized clinical trials comparing…”
Get full text

High Specificity in Circulating Tumor Cell Identification Is Required for Accurate Evaluation of Programmed Death-Ligand 1 by Schehr, Jennifer L, Schultz, Zachery D, Warrick, Jay W, Guckenberger, David J, Pezzi, Hannah M, Sperger, Jamie M, Heninger, Erika, Saeed, Anwaar, Leal, Ticiana, Mattox, Kara, Traynor, Anne M, Campbell, Toby C, Berry, Scott M, Beebe, David J, Lang, Joshua M

“…Expression of programmed-death ligand 1 (PD-L1) in non-small cell lung cancer (NSCLC) is typically evaluated through invasive biopsies; however, recent…”
Get full text

Integrated Onco-Palliative Care Associated with Prolonged Survival Compared to Standard Care for Patients with Advanced Lung Cancer: A Retrospective Review by King, Jonathan D., MD, Eickhoff, Jens, PhD, Traynor, Anne, MD, Campbell, Toby C., MD, MSCI

“…Abstract Context Lung cancer is the leading cause of cancer-related death in the United States. A large randomized controlled trial in advanced lung cancer…”
Get full text

Best Case/Worst Case: protocol for a multisite randomised clinical trial of a scenario planning intervention for patients with kidney failure by Haug, Karlie, Buffington, Anne, Zelenski, Amy, Hanlon, Bret M, Stalter, Lily, Kwekkeboom, Kristine L, Rathouz, Paul, Bansal, Amar D, Cheung, Katharine, Crews, Deidra, Frazier, Rebecca, Koncicki, Holly, Lam, Daniel, Moss, Alvin, Rao, Maya, Wolfgram, Dawn F, Yi, Jeniann, Brill, Carrie, Kendrick, Rachael, Campbell, Toby C, Jhagroo, Roy, Schwarze, Margaret

“…IntroductionGiven the burdens of treatment and poor prognosis, older adults with kidney failure would benefit from improved decision making and palliative care…”
Get full text

Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer by Traynor, Anne M, Weigel, Tracey L, Oettel, Kurt R, Yang, David T, Zhang, Chong, Kim, KyungMann, Salgia, Ravi, Iida, Mari, Brand, Toni M, Hoang, Tien, Campbell, Toby C, Hernan, Hilary R, Wheeler, Deric L

“…Abstract Introduction Nuclear EGFR (nEGFR) has been identified in various human tumor tissues, including cancers of the breast, ovary, oropharynx, and…”
Get full text

A Quantitative Study of Triggered Palliative Care Consultation for Hospitalized Patients With Advanced Cancer by Rocque, Gabrielle B., MD, Campbell, Toby C., MD, Johnson, Sara K., MD, King, Jonathan, MD, Zander, Meghan R, Quale, Renae M., RN, Eickhoff, Jens C., PhD, Cleary, James F., MD

“…Abstract Context Unplanned cancer-related hospital admissions often herald entry into the final phase of life. Hospitalized patients with advanced cancer have…”
Get full text

Embedding an Education Intervention about Shared Decision Making into an RCT: Ensuring competency and fidelity by Zelenski, Amy B., Haug, Karlie, Bushaw, Kyle J., Buffington, Anne, Bradley, Taylor, Kwekkeboom, Kristine L., Stalter, Lily, Hanlon, Bret M., Wakeen, Maureen J., Jhagroo, Roy A., Maursetter, Laura J., Johnson, Sara K., Campbell, Toby C., Schwarze, Margaret L.

“…To describe the outcomes of training nephrology clinicians and clinical research participants, to use the Best Case/Worst Case Communication intervention, for…”
Get full text

Myosteatosis as a Shared Biomarker for Sarcopenia and Cachexia Using MRI and Ultrasound by Lortie, Jevin, Rush, Benjamin, Osterbauer, Katie, Colgan, T. J., Tamada, Daiki, Garlapati, Sujay, Campbell, Toby C., Traynor, Anne, Leal, Ticiana, Patel, Viharkumar, Helgager, Jeffrey J., Lee, Kenneth, Reeder, Scott B., Kuchnia, Adam J.

“…Purpose Establish bedside biomarkers of myosteatosis for sarcopenia and cachexia. We compared ultrasound biomarkers against MRI-based percent fat, histology,…”
Get full text

Best Case/Worst Case: ICU (COVID-19)—A Tool to Communicate with Families of Critically Ill Patients with COVID-19 by Schwarze, Margaret L, Zelenski, Amy, Baggett, Nathan D, Kalbfell, Elle, Ljumani, Fiona, Silverman, Ethan, Campbell, Toby C

“…During the COVID-19 pandemic, critically ill patients have been hospitalized and strictly isolated. In March 2020, palliative care clinicians at the University…”
Get full text

Corrigendum: Myosteatosis as a Shared Biomarker for Sarcopenia and Cachexia Using MRI and Ultrasound by Lortie, Jevin, Rush, Benjamin, Osterbauer, Katie, Colgan, T. J., Tamada, Daiki, Garlapati, Sujay, Campbell, Toby C., Traynor, Anne, Leal, Ticiana, Patel, Viharkumar, Helgager, Jeffrey J., Lee, Kenneth, Reeder, Scott B., Kuchnia, Adam J.

Get full text

Renaming Palliative Cancer Therapies: Call It What It Is by Kopecky, Kimberly E, Campbell, Toby C

“…This commentary explores the language choices that oncology providers make when discussing cancer therapy goals…”
Get full text

A Framework to Improve Surgeon Communication in High-Stakes Surgical Decisions: Best Case/Worst Case by Taylor, Lauren J, Nabozny, Michael J, Steffens, Nicole M, Tucholka, Jennifer L, Brasel, Karen J, Johnson, Sara K, Zelenski, Amy, Rathouz, Paul J, Zhao, Qianqian, Kwekkeboom, Kristine L, Campbell, Toby C, Schwarze, Margaret L

“…Although many older adults prefer to avoid burdensome interventions with limited ability to preserve their functional status, aggressive treatments, including…”
Get more information

The Utilization of Palliative Care Services in Patients with Cirrhosis who have been Denied Liver Transplantation: A Single Center Retrospective Review by Kelly, Sean G, Campbell, Toby C, Hillman, Luke, Said, Adnan, Lucey, Michael R, Agarwal, Parul D

“…AbstractIntroduction and AimUtilization of palliative care services in patients dying of end-stage liver disease (ESLD) is understudied. We performed a…”
Get full text

Creating space to discuss end-of-life issues in cancer care by Cortez, Dagoberto, Maynard, Douglas W., Campbell, Toby C.

“…•“Exhausted current treatment” (ECT) statements are used to report serious news.•ECT statements bypass talk of scan results and instead focus on treatment…”
Get full text

The establishment and future of integrated onco‐palliative care by Jan, M. Yahya, Campbell, Toby C.

“…Over the last decade, palliative care has successfully expanded to firmly establish its role in the clinical management of people with serious illness. To…”
Get full text

When Minutes Matter by Campbell, Toby C

“…Campbell talks about his patient named Keith, who had lower motor neuron disease and had been admitted with hypercarbic respiratory failure following a…”
Get full text

Balancing risks and rewards: How hematologists discuss uncertainty in allogeneic hematopoietic cell transplantation outcomes by Rodenbach, Rachel A., Thordardottir, Thorunn, Brauer, Markus, Hall, Aric C., Ward, Earlise, Smith, Cardinale B., Campbell, Toby C.

“…Allogeneic hematopoietic cell transplant (alloHCT) offers many patients with blood cancers a chance of cure but carries risks. We characterized how…”
Get full text